Cover 2 Resources
Cover 2 Resources
Ep. 237 - Understanding Purdue Pharma’s Settlement with Oklahoma
Ep. 237 - Understanding Purdue Pharma’s Settlement with Oklahoma
Ep. 237 - Understanding Purdue Pharma’s Settlement with Oklahoma
Wednesday 17th April 2019
Explore Purdue Pharma's $270 million settlement with Oklahoma and its impact on the opioid crisis in this Cover2 Resources episode.
29 minutes
Informative
Thought-provoking
Raw
Engaging
Educational
About this podcast
Overview:
Categories:
Innovative Treatments & Recovery Paths
Family Recovery from Addiction
Sobriety Toolkit
Body & Mind
Navigating Intimate Relationships
Links:
Visit site
Episodes:
284 (View all)
Do you want to link to this podcast?
Get the buttons here!The Ripple Effect of Purdue Pharma's $270 Million Settlement with Oklahoma
It's absolutely enormous, if you think of it, the general public perception, and I haven't seen any statistics on this, any kind of polling. That would garner much more media attention.
What happens when a pharmaceutical giant faces a landmark settlement? This episode of Cover2 Resources digs into Purdue Pharma's $270 million agreement with the State of Oklahoma, a pivotal moment in the ongoing opioid crisis. The settlement, reached on March 26, 2019, has far-reaching implications, from funding a national addiction research and treatment center to setting a precedent for over 1,600 pending cases against Purdue.
The episode features insights from Andrew Pollis, a professor at Case Western Reserve University School of Law, who helps break down the legal intricacies and the broader impact of this case. The conversation touches on bankruptcy issues, involuntary petitions, and multi-district litigation, offering a thorough understanding of the legal landscape. Additionally, the hosts discuss how media coverage of the opioid epidemic could influence future legislative actions.
If you're keen to understand the deeper layers of this significant settlement and its potential ripple effects on the opioid crisis, this episode is a must-listen.